首页> 外文期刊>Clinical practice and epidemiology in mental health >Prevalence of cataract in adult Down's syndrome patients aged 28 to 83 years
【24h】

Prevalence of cataract in adult Down's syndrome patients aged 28 to 83 years

机译:28至83岁的成人唐氏综合症患者的白内障患病率

获取原文
           

摘要

Background Age-related cataract is the major cause of blindness in humans throughout the world. The majority of previous studies of cataract in Down's syndrome (which usually results from trisomy 21) have reported that the prevalence of this ocular abnormality is higher for a given age range than in the general population. The objective of the present study was to study the prevalence of cataract in a well-defined population of adults with Down's syndrome. Methods An in-patient population of 68 adults (35 males and 33 females) with Down's syndrome, aged between 28.9 and 83.3 years, underwent ophthalmological examination for the presence of cataracts. Results Overall, the prevalence of cataract was 16.2%, with no significant difference in the prevalence between males (17.1%) and females (15.2%). In those aged between 45 and 64 years, the prevalence was 16.7%, rising in those aged between 65 and 75 years to 28.6%. Conclusion Compared with the general population, the prevalence of cataract in Down's syndrome was raised in those aged 45 to 64, but not in those aged 65 to 75 years; the latter might be a function of the relatively small number of patients in this age group. The increased prevalence of cataract found in those in the 45- to 64-year-old age group may be the result of increased levels of the copper- and zinc-containing superoxide dismutase enzyme (CuZnSOD), in turn resulting from the location of the associated five exons of SOD1 on chromosome 21. These elevated levels of superoxide dismutase may give rise to increased levels of reactive species, including hydrogen peroxide and hydroxyl radicals, which may increase the risk of cataractogenesis. It is suggested that nutritional supplementation with antioxidants may therefore help reduce the prevalence of cataract in Down's syndrome.
机译:背景技术与年龄有关的白内障是全世界人类失明的主要原因。以前的大多数唐氏综合症白内障研究(通常由21三体症引起)都报告说,在给定的年龄范围内,这种眼部异常的患病率高于一般人群。本研究的目的是研究明确定义的唐氏综合症成年人群中的白内障患病率。方法对68例唐氏综合症患者(年龄在28.9至83.3岁之间)的住院患者进行眼科检查,检查是否存在白内障。结果总体而言,白内障患病率为16.2%,其中男性(17.1%)和女性(15.2%)的患病率无显着差异。在45至64岁之间的人群中,患病率为16.7%,在65至75岁之间的人群中的患病率上升至28.6%。结论与一般人群相比,唐氏综合症的白内障患病率在45岁至64岁的人群中有所增加,但在65岁至75岁的人群中却没有。后者可能是该年龄段相对少数患者的功能。在45至64岁年龄段的人群中,白内障患病率增加可能是由于含铜和锌的超氧化物歧化酶(CuZnSOD)含量升高的结果,而这又是由于白内障的位置与21号染色体上SOD1的五个外显子相关。这些升高的超氧化物歧化酶水平可能导致反应性物质(包括过氧化氢和羟​​基自由基)的水平升高,这可能会增加白内障发生的风险。建议用抗氧化剂进行营养补充可能有助于降低唐氏综合症中白内障的患病率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号